Age, mean ± SD, years |
68 ± 8 |
65 ±7.6 |
77± 2.8 |
73 |
Male Gender |
50% (9/18) |
30% |
100% |
0 |
African American race |
16.7% (3/18) |
20% |
0 |
0 |
Immunosuppression |
33.3% (6/18) |
30% |
50% |
100% |
Body mass index |
33.8 ± 12.3 |
34.1±2.6 |
23.8±2.6 |
43.7 |
Diabetes mellitus |
77.8% (14/18) |
70% (7/10) |
100% (2/2) |
100%
(1/1) |
Days of intubation prior to BAL, mean ±SD |
3.6 ± 3.6 |
3.3±2.1 |
4±4.2 |
1 |
Days from symptoms to BAL |
13.6 ± 7.8 |
13.8±7.5 |
13.5±2.1 |
19 |
Dexamethasone prior to BAL |
100% (18/18) |
100% (10/10) |
100% (2/2) |
100% (1/1) |
Tocilizumab prior to BAL |
0 |
0 |
50% (1/2) |
0 |
Remdesivir prior to BAL |
55.6% (10/18) |
50% (5/10) |
50% (1/2) |
100% (1/1) |
Max temperature*, mean ± SD, 0C |
37.7 ±1.1 |
37.4
±0.8 |
38.3 ±1.1 |
40.1 |
Vasopressors* |
72.2% (13/18) |
70% (7/10) |
100% (2/2) |
0
(0/1) |
Min PaO2/FiO2* |
161.4 ± 93.2 |
168.7±120.7 |
101.2±18.6 |
148 |
CRP*, mean±SD, mg/L |
155.2 ± 117.1 |
117.2±72.8 |
141.4±90.8 |
Not
available |
Max WBC*, mean ± SD, cells/µL |
13.3 ± 6.3 |
12.9±5.6 |
13.4±3.5 |
7.7 |
Min lymphocyte count*, mean ± SD cells/µL |
0.7 ± 0.4 |
0.5±0.3 |
1.2±0.6 |
0.5 |
BAL neutrophil % |
38.5 ± 29.8 |
31±29.2 |
14 |
38 |
BAL lymphocyte % |
8.4 ± 8.7 |
8±7.5 |
5 |
28 |
Ct value, mean ± SD |
22 ± 6.5 |
23.4±5.6 |
23.6±6.2 |
14.4 |
IL-6 plasma, mean ± SD, pg/ml |
1630.7±5383 |
160.4±306.6 |
9778.1±13782.8†
|
38.5 |
IFN-γ plasma, mean ± SD, pg/ml |
0.7±0.2 |
0.6±0 |
1±0.3 |
0.6 |
IL-1β plasma, mean ± SD, pg/ml |
0.87±0.8 |
0.7±0.5 |
1.9±1.2 |
0.2 |
IL-8 plasma, mean ± SD, pg/ml |
48.4±42.9 |
40.4±39.2 |
44.9±6.6 |
135.1 |
IL-10 plasma, mean ± SD, pg/ml |
75±178.3 |
93.3±201.9 |
14.7±20.1 |
12.7 |
IL-12 plasma, mean ± SD, pg/ml |
42.5±29.1 |
37.9±30 |
71.3±8.1 |
31.6 |
MIP-1β plasma, mean ± SD, pg/ml |
223.7±470.7 |
83.3±62.7 |
151±1208.5 |
1773.2 |
MCP-1 plasma, mean ± SD, pg/ml |
994.5±759.7 |
978.2±848.9 |
955±613.3 |
1237.5 |
IP-10 plasma, mean ± SD, pg/ml |
183.3±229.6 |
111.9±67.3 |
613.5±386.4 |
37.8 |
Ventilator- free days, mean ± SD |
1.8 +/- 2.9 |
1.7±2.9 |
1.5±2.1 |
0 |
Length of stay, mean ± SD, days |
31.1 ± 15.6 |
29.9±14.2 |
38±15.6 |
8 |
Mortality |
66.7% (12/18) |
80% (8/10) |
50% (1/2) |
100%
(1/1) |